[HTML][HTML] Targeting AMPK signaling as a neuroprotective strategy in Parkinson's disease
DW Curry, B Stutz, ZB Andrews… - Journal of Parkinson's …, 2018 - content.iospress.com
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is
characterized by the accumulation of intracellular α-synuclein aggregates and the …
characterized by the accumulation of intracellular α-synuclein aggregates and the …
Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease.
DW Curry, B Stutz, ZB Andrews… - Journal of Parkinson's …, 2018 - europepmc.org
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is
characterized by the accumulation of intracellular α-synuclein aggregates and the …
characterized by the accumulation of intracellular α-synuclein aggregates and the …
[PDF][PDF] Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease
DW Currya, B Stutza, ZB Andrewsc… - Journal of Parkinson's …, 2018 - research.monash.edu
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is
characterized by the accumulation of intracellular-synuclein aggregates and the …
characterized by the accumulation of intracellular-synuclein aggregates and the …
[HTML][HTML] Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease
DW Curry, B Stutz, ZB Andrews… - Journal of Parkinson's …, 2018 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is
characterized by the accumulation of intracellular α-synuclein aggregates and the …
characterized by the accumulation of intracellular α-synuclein aggregates and the …
Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease
DW Curry, B Stutz, ZB Andrews… - Journal of Parkinson's …, 2018 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is
characterized by the accumulation of intracellular α-synuclein aggregates and the …
characterized by the accumulation of intracellular α-synuclein aggregates and the …
[HTML][HTML] Targeting AMPK signaling as a neuroprotective strategy in Parkinson's disease
DW Curry, B Stutz, ZB Andrews… - Journal of Parkinson's …, 2018 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is
characterized by the accumulation of intracellular α-synuclein aggregates and the …
characterized by the accumulation of intracellular α-synuclein aggregates and the …
Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease.
DW Curry, B Stutz, ZB Andrews… - Journal of Parkinson's …, 2018 - europepmc.org
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is
characterized by the accumulation of intracellular α-synuclein aggregates and the …
characterized by the accumulation of intracellular α-synuclein aggregates and the …
Targeting AMPK signaling as a neuroprotective strategy in Parkinson's disease
DW Curry, B Stutz, ZB Andrews… - Journal of Parkinson's …, 2018 - research.monash.edu
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is
characterized by the accumulation of intracellular α-synuclein aggregates and the …
characterized by the accumulation of intracellular α-synuclein aggregates and the …